Skip to main content
Displaying 1 - 12 of 28
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Immune-Mediated and Cholestatic Diseases
6
Intercept: Providing Better Care in PBC – understanding the evolving evidence - ILC 2021
View
Viral Hepatitis
2
GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021
View
Viral Hepatitis
2
GSK: HBsAg clearance in chronic hepatitis B: How close is it? - ILC 2021
View
Viral Hepatitis
6
AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021
View
Viral Hepatitis
6
AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021
View
Viral Hepatitis
6
AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021
View
Viral Hepatitis
6
AbbVie: The Road to HCV Elimination: Always Forward - ILC 2021
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy